The most striking feature of the H1N1 flu vaccine manufacturing process is the 1,200,000,000 chicken eggs required to make the 3 billion doses of vaccine that may be required worldwide. There are entire chicken farms in the US and around the world dedicated to producing eggs for the purpose of incubating influenza viruses for use in vaccines. No wonder it takes six months from start to finish. But we'll get to that in a minute.
Posted by: Anonymous on November 25, 2009 at 6:09 AM
VLP technology
Check out the new methods for producing vaccines that companies like Novavax (NVAX) are pioneering. It's called VLP or virus-like particles. I'm convinced this is the future of vaccine making... http://en.wikipedia.org/wiki/Virus-like_particle
Posted by: alandove on November 25, 2009 at 7:48 AM
Old School
I'm glad people are starting to pay more attention to vaccine production. There are indeed some very exciting new technologies coming online for this, and it's about time. It seems odd that the production schedule for a 21st-century drug still relies on the schedules of chicken farmers.
Shameless plug: if you'd like to hear a few virologists discussing both new and old vaccine production platforms, it's been a pretty frequent topic on recent episodes of This Week in Virology (http://twiv.tv).
Void your warranty, violate a user agreement, fry a circuit, blow a fuse, poke an eye out. Make: The risk-takers, the doers, the makers of things... Welcome to Make: Online!
More contributors: Mark Frauenfelder (Editor-in-Chief, MAKE magazine), Kipp Bradford (Technical Consultant/Writer), Chris Connors (Education), Diana Eng (Guest Author), Peter Horvath (Intern), Brian Jepson (O'Reilly Media), Robert Bruce Thompson (Science Room)
Behind the Scenes at MAKE and CRAFT
In January, many of the remote MAKE/CRAFT team members (myself included) convened at the Maker Media headquarters at O'Reilly Media in Sebastopol, California. Take a look behind the scenes of your favorite DIY publications as Goli Mohammadi gives us...
More...
Sign up for the Make: Newsletter
Our Make: Newsletter covers news from maker Media, has original columns, Shed deals, and more! You can also read the archives of past issues.
RSS
Check out the new methods for producing vaccines that companies like Novavax (NVAX) are pioneering. It's called VLP or virus-like particles. I'm convinced this is the future of vaccine making...
http://en.wikipedia.org/wiki/Virus-like_particle
Reply to this comment
I'm glad people are starting to pay more attention to vaccine production. There are indeed some very exciting new technologies coming online for this, and it's about time. It seems odd that the production schedule for a 21st-century drug still relies on the schedules of chicken farmers.
Shameless plug: if you'd like to hear a few virologists discussing both new and old vaccine production platforms, it's been a pretty frequent topic on recent episodes of This Week in Virology (http://twiv.tv).
Reply to this comment